To view this email as a web page, click here

Today's Rundown

Featured Story

Pfizer, Moderna COVID vaccines face new safety probe in Europe over possible link to skin condition, 2 kidney disorders

The European Medicines Agency is trying to determine if mRNA vaccines can trigger an allergic skin reaction called erythema multiforme or two kidney disorders. It has requested additional data from Pfizer, BioNTech and Moderna.

read more

Top Stories

Biogen's controversial Alzheimer's med Aduhelm turned away by VA on efficacy and safety worries

The Department of Veterans Affairs decided not to include Biogen’s drug aducanumab on its formulary, which its pharmacy benefit manager (PBM) credited to a “lack of evidence of a robust and meaningful clinical benefit,” plus safety concerns.

read more

Aetna launching nationwide virtual primary care solution

The new solution is backed by Teladoc Health's physician-led care team model and harnesses Aetna's provider network and the slate of services provided by CVS Health, the insurer's parent company.

read more

As biotech debates vaccine mandates, one CEO tries to convince the 3% that got away

The Delta variant has sent shockwaves across the world as people began to emerge from more than a year of isolation. The workplace has become a new line of defense against the pandemic. Fierce Biotech surveyed a range of biotechs to see how they are responding to the wave of vaccination mandates.

read more

HIMSS21: Your healthcare organization is crippled by ransomware. Should you pay the attackers?

There are few incentives for hamstrung health organizations to hold out against their cyberattackers. But whether they decide to pay, hospitals and payers can take steps to improve their chances during a ransomware crisis, experts said at HIMSS21.

read more

Big Pharma’s Q2 growth, ranked: Regeneron, Pfizer lead the way as sales rebound from pandemic depths

Drug sales are up, with some therapy areas rebounding faster than others, quarterly earnings show. And while the recovery is underway, there’s still a long ride ahead to return to the industry’s pre-pandemic landscape. 

read more

BD finds new global finance chief in 20-year Johnson & Johnson vet

In his new role, DelOrefice will oversee not only the company’s entire global finance organization, but also its technology and global services business division, replacing retiring CFO Christopher Reidy.

read more

Texas governor asks hospitals to delay elective procedures amid COVID surge

Texas Gov. Greg Abbott is asking hospitals to voluntarily halt elective procedures and for out-of-state staffing help as COVID-19 surges.

read more

Overcoming resistance to cancer immunotherapy by targeting garbage-cleaning cells in tumors

Combining immunotherapy, anti-angiogenic drugs and chemotherapy to treat non-small cell lung cancer hasn't proven to be all that effective. Now, a new study suggests that a four-drug combination including a CSF1R inhibitor can target tumor-associated macrophages and improve the anti-tumor response.

read more

Lawsuit charges HCA operating hospital monopoly in North Carolina

North Carolina residents are suing HCA Healthcare, charging the hospital system with operating a monopoly in the western part of the state.

read more

COVID-19 tracker: CDC recommends vaccines for pregnant women; California to require jabs for teachers, school staff

The CDC now recommends pregnant women get vaccinated against the virus, saying the benefits outweigh any known risks. California has become the first state to require its school teachers and staff to get vaccinated against COVID-19 or face weekly testing. Plus more headlines.

read more